echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Fosun Pharma will only provide guarantee quota to eligible H-share shareholders of Fosun Pharma in connection with the listing of Fosun pharma.

    Fosun Pharma will only provide guarantee quota to eligible H-share shareholders of Fosun Pharma in connection with the listing of Fosun pharma.

    • Last Update: 2019-08-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Fosun Pharmaceutical announced on the evening of November 21, 2018, The first extraordinary general meeting of shareholders of Shanghai Fosun Pharmaceutical (Group) Co., Ltd in 2018 deliberated and approved the relevant matters of Shanghai Fuhong Hanlin Biotechnology Co., Ltd (and its initial public offering of overseas listed foreign shares (H shares) and listing on the main board of the stock exchange of Hong Kong Limited); on the same day, the first extraordinary general meeting of shareholders of the company in 2018, 2018 The first A-share shareholders' meeting in 2018 and the first H-share shareholders' meeting in 2018 also deliberated and approved the proposal that Hong Hanlin would only provide guaranteed quota to H-share shareholders of the company in the overseas listing According to the authorization of the above-mentioned general meeting of shareholders and the class of shareholders' meeting, Fosun Pharmaceutical will only provide guarantee quota to the qualified Fosun Pharmaceutical H-share shareholders (that is, it is proposed to offer Fosun Pharmaceutical H-share to the qualified Fosun Pharmaceutical H-share shareholders in the global offering of Fosun Hanlin, hereinafter referred to as the "preferred offering") According to Article 23 of the detailed rules for the implementation of the registration, depository and settlement business of the trading interconnection mechanism between the mainland and Hong Kong stock market, China Securities Depository and Clearing Co., Ltd does not provide services such as new share issuance and subscription, over allotment and over allotment Accordingly, even if the preferred offering is carried out, the beneficial holders of H shares of the company held through Shanghai Hong Kong stock connect or Shenzhen Hong Kong stock connect will not be able to participate in the preferred offering, that is, they will not be able to obtain the guaranteed quota of H shares of zhongfuhong Hanlin through the trading mechanism of Shanghai Hong Kong stock connect or Shenzhen Hong Kong stock connect.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.